Lundbeck updates on clinical phase III study for Lu AF35700 in Treatment-Resistant SchizophreniaP&T Communityii Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J; American Psychiatric Association; Steering Committee on Pr